A novel Silva pattern-based model for precisely predicting recurrence in intermediate-risk cervical adenocarcinoma
Chenyan Guo1,2, Xiang Tao1,2, Lihong Zhang1,2
1Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, 419 Fangxie Road, Shanghai, 200011, China.
BMC Women'S Health
|September 16, 2022
Summary
A new Silva-based model accurately predicts recurrence in intermediate-risk cervical adenocarcinoma (AC) patients. This model surpasses existing criteria, offering improved guidance for adjuvant therapy decisions in AC.
Area of Science:
- Gynecologic Oncology
- Pathology
- Cancer Prognostics
Background:
- Cervical adenocarcinoma (AC) exhibits unique biology, necessitating distinct prognostic methods.
- Current methods for assessing intermediate-risk AC patients are insufficient.
- There is a need for a specific model to predict recurrence and guide therapy in AC.
Purpose of the Study:
- To develop a Silva-based model for predicting recurrence in intermediate-risk AC patients.
- To guide adjuvant therapy decisions for AC patients.
- To improve prognostic assessment for AC.
Main Methods:
- Classified 345 AC patients based on Silva pattern and clinicopathological data.
- Identified 254 intermediate-risk AC patients.
- Utilized Cox analyses to determine significant factors (tumor size, LVSI, DSI, Silva pattern) and developed multi-factor Silva-based models.
Main Results:
- Confirmed the prognostic value of the Silva pattern in AC.
- Established multiple Silva-based models for recurrence prediction in intermediate-risk AC.
- A four-factor Silva-based model demonstrated superior recurrence prediction compared to the Sedlis criteria.
Conclusions:
- A novel four-factor Silva-based model is effective for intermediate-risk AC patients.
- This model offers enhanced recurrence prediction over the Sedlis criteria.
- The model can potentially optimize postoperative adjuvant therapy for AC.
